Robert J. Wenthold (Bob) grew up on a farm outside of Cresco, Iowa, a small town near the Minnesota border. Anyone who knew Bob would acknowledge that he never lost the midwestern work ethic gained during his formative years. After high school, Bob left the farm and went to Loras College, a small liberal arts college in Dubuque, Iowa. Following the completion of his undergraduate degree, he pursued graduate studies at Indiana University working with Dr. Henry Mahler to characterize the biochemical properties of synaptic proteins. Bob came to the NIH for the first time as a postdoctoral fellow in the laboratory of Jorgen Fex. Together, they characterized the expression of different neurotransmitters within the auditory system, including a landmark paper in Science in 1978 that was the first to provide evidence that glutamate is the primary excitatory neurotransmitter in the cochlear nucleus. Bob left NIH to join the faculty in the Department of Neurophysiology at the University of Wisconsin, but returned in 1984 to become a tenured Senior Investigator in the National Institute of Neurological and Communicative Disorders and Stroke (NINCDS), where he remained until 1989 when he was a founding member of the intramural program in the newly formed National Institute on Deafness and Other Communication Disorders (NIDCD).
Throughout his scientific career, Bob's interests were focused on synaptic transmission and the biochemistry and localization of synaptic proteins. Early in his career, he published extensively on the neuroanatomy of both the peripheral and central auditory systems with an emphasis on the distribution of neurotransmitters and their possible roles in hearing function. Many of these studies were coauthored by Richard Altschuler, a member of the Laboratory of NeuroOtolaryngology at the NINCDS in the mid-80s. This collaboration and friendship would extend well beyond their mutual time at NIH, with their final coauthored paper appearing in 1996.
In the early 1990s, Bob decided to cross the synaptic cleft and focus his energy on postsynaptic proteins. In particular, he was trying to purify glutamate receptors using biochemical techniques just when the functional cloning of the first mammalian AMPA receptor, GluR1, was reported by Steve Heinemann's laboratory. This breakthrough was followed rapidly by the cloning of the three other AMPA receptor subunits by Peter Seeburg's group. Bob rapidly took advantage of this sequence information and generated antibodies specific for each subunit, allowing for the biochemical and immunocytochemical analysis of the receptors. Over the years, his antibodies have been used by hundreds of labs. In 1991, Ron Petralia joined Bob's laboratory to provide expertise in electron microscopy. The combination of Bob's antibodies and Ron's EM skills led to an exciting and timely characterization of the subcellular distribution of these receptors. For the next decade, Bob's team, which included many talented postdoctoral fellows and students, probed the synaptic organization of glutamate receptors and associated proteins using molecular, biochemical, and morphological techniques, leading to a series of high-impact papers. More recently, Bob's growing appreciation of the dynamic nature of the PSD led him to focus on the trafficking of NMDA receptors and the molecular mechanisms regulating their targeting to synapses.
Bob's scientific contributions, like the man himself, were often elegantly understated. His landmark studies on the biochemistry of AMPA receptors are the foundations for our current understanding of these proteins. The first study demonstrating the oligomerization of GluR1-4 appeared in JBC in 1992 (Wenthold et al., 1992) and showed that the four homologous subunits (GluR1-4) assembled in native brain tissue. Though a tenured Senior Investigator at the time, Bob was first author on this paper because he had performed the majority of the biochemical assays himself. Another high-profile study conducted primarily by Bob defined the stoichiometry of AMPA receptors expressed in the CA1 region of the hippocampus (Wenthold et al., 1996) . Over a decade later, this work is still the centerpiece for the working hypothesis for subunit-specific AMPA receptor assembly.
Throughout his career, Bob's contributions to the field extended beyond his own laboratory. A hallmark of Bob's approach to science was his collaborative nature; he worked with labs around the world, especially helping groups lacking EM expertise characterize the distribution of their proteins of interest at synapses. In addition, he served on a number of editorial boards, including Bob was a leader among the Scientific Directors of the NIH intramural programs. As Story Landis described him, ''He was a midwesterner through and throughhe never said much, but when he did everyone listened. People trusted him to do the right thing and he could be counted on to put the interests of the community above those of his own program and his institute.'' In addition to his scientific legacy through his leadership and support, he made the notion of one community of neuroscientists at the NIH a reality. A final piece of this vision will be the move of NIDCD scientists to the Porter Neuroscience Research Center when it is completed in 2013.
Bob was a beloved mentor, sharing his infectious passion for science with many trainees throughout his career. His door was always open, literally and figuratively, and he would enthusiastically pull over a chair to analyze a western blot or get up and go look through the microscope. He loved poring over the raw data and trying to put the pieces of the puzzle together with members of his lab. He was enthusiastic, supportive, and extremely funny. Bob's dry sense of humor often caught people by surprise, but made interactions with him all the more enjoyable. His unique personality, work ethic, and enthusiasm made his influence over his fellows profound. Bob's role as mentor was most recently recognized when he was awarded the NIH GPP Outstanding Mentor Award in 2008. His legacy lives on through his former fellows and students who have gone on to influence neuroscience across North America, Europe, and Asia.
For over two years, Bob waged a battle with renal cancer. He continued working throughout his illness, coming to the lab and mentoring his group until just before his death. As he told me over a year ago, ''There has never been a day that I didn't enjoy getting up and going to work.'' Neuroscience was his passion and a source of joy and fulfillment for him, which permeated all his interactions with colleagues. Over the years, I often referred to Bob as an ''overgrown postdoc,'' which invariably elicited a big grin. Furthermore, Bob and I had an agreement that I would save a bench for him in my lab and that it would be waiting when he retired. Although these exchanges were accompanied by a smile and a chuckle, I never considered them to be entirely in jest. It would have been perfectly fitting for Bob to eventually retire from his administrative responsibilities and focus his time and energy more completely on research.
Bob passed away on October 30 th at home surrounded by his loving family. It is inevitable that his NIH colleagues, past and present trainees, and collaborators around the world now feel cheated that Bob was taken so early. The neuroscience community has lost a valued scientist. We will be denied his future research contributions and the warm interpersonal interactions with our friend and colleague. With his intense dedication to research and his boyish enthusiasm, Bob continually reminded us that it is, indeed, a privilege and a joy to wake up each day and pursue our passions. He will truly be missed. 
